Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis.
Sign Up to like & getrecommendations! Published in 2021 at "ACS infectious diseases"
DOI: 10.1021/acsinfecdis.1c00213
Abstract: The lengthy treatment time for tuberculosis (TB) is a primary cause for the emergence of multidrug resistant tuberculosis (MDR-TB). One approach to improve TB therapy is to develop an inhalational TB therapy that when administered… read more here.
Keywords: preclinical evaluation; spectinamide 1599; tuberculosis; therapy ... See more keywords